We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+4.73%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.72B
AUM Growth
+$141M
Cap. Flow
+$95.8M
Cap. Flow %
5.57%
Top 10 Hldgs %
21.85%
Holding
2,270
New
651
Increased
413
Reduced
537
Closed
573

Sector Composition

Rank Sector Weight
1 Technology 14.61%
2 Healthcare 9.84%
3 Financials 8.44%
4 Communication Services 8.41%
5 Energy 5.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACLS icon
1351
Axcelis
ACLS
$4.33B
$15K ﹤0.01%
742
-1,591
-68% -$32.8K
AIRG icon
1352
Airgain
AIRG
$72.4M
$15K ﹤0.01%
1,116
-225
-17% -$2.53K
AMPY icon
1353
Amplify Energy
AMPY
$166M
$15K ﹤0.01%
+1,700
New +$20.1K
AMSC icon
1354
American Superconductor
AMSC
$1.59B
$15K ﹤0.01%
2,100
+500
+31% +$2.98K
AORT icon
1355
Artivion
AORT
$1.32B
$15K ﹤0.01%
417
+316
+313% +$10.2K
BRKR icon
1356
Bruker
BRKR
$8.14B
$15K ﹤0.01%
457
+181
+66% +$5.96K
CBUS icon
1357
Cibus
CBUS
$138M
$15K ﹤0.01%
+20
New +$17.2K
CRAK icon
1358
VanEck Oil Refiners ETF
CRAK
$253M
$15K ﹤0.01%
+417
New +$14.1K
EPAM icon
1359
EPAM Systems
EPAM
$5.03B
$15K ﹤0.01%
+110
New +$14.8K
KALV
1360
DELISTED
KalVista Pharmaceuticals
KALV
$15K ﹤0.01%
656
-378
-37% -$5.11K
LGND icon
1361
Ligand Pharmaceuticals
LGND
$6.36B
$15K ﹤0.01%
+90
New +$13.6K
NVMI
1362
Nova
NVMI
$12.5B
$15K ﹤0.01%
582
-281
-33% -$7.77K
RGNX icon
1363
Regenxbio
RGNX
$708M
$15K ﹤0.01%
200
-9,125
-98% -$657K
TLYS icon
1364
Tilly's
TLYS
$128M
$15K ﹤0.01%
795
-1,946
-71% -$33.5K
TRN icon
1365
CALL
Trinity Industries
TRN
$2.38B
$15K ﹤0.01%
+556
New +$14.6K
ULBI icon
1366
Ultralife
ULBI
$106M
$15K ﹤0.01%
1,879
-885
-32% -$8.27K
UNFI icon
1367
United Natural Foods
UNFI
$2.85B
$15K ﹤0.01%
500
-9,082
-95% -$329K
UVV icon
1368
Universal Corp
UVV
$1.27B
$15K ﹤0.01%
+235
New +$15K
WEYS icon
1369
Weyco Group
WEYS
$440M
$15K ﹤0.01%
428
+328
+328% +$11.9K
IIN
1370
DELISTED
IntriCon Corporation
IIN
$15K ﹤0.01%
270
-256
-49% -$15K
CUB
1371
DELISTED
Cubic Corporation
CUB
$15K ﹤0.01%
+200
New +$14.3K
AQ
1372
DELISTED
Aquantia Corp. Common Stock
AQ
$15K ﹤0.01%
1,200
-1,400
-54% -$17.7K
TAHO
1373
CALL
DELISTED
Tahoe Resources Inc
TAHO
$15K ﹤0.01%
+5,400
New +$20.9K
GCI
1374
DELISTED
Gannett Co., Inc
GCI
$15K ﹤0.01%
1,500
-5,200
-78% -$53.3K
ADT icon
1375
CALL
ADT
ADT
$5.58B
$14K ﹤0.01%
+1,500
New +$13.4K

Similar funds

Prelude Capital Management's Q3 2018 Portfolio in Review

As of Q3 2018, Prelude Capital Management held 2,270 positions worth $1.72B, up 8.9% from $1.58B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Prelude Capital Management deployed $95.8M of net new capital in Q3 2018, opening 651 new positions and adding to 413 existing holdings. Its largest new stake was SodaStream International Ltd: 71,388 shares worth $10.2M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was NXP Semiconductors, an estimated $20.6M trimmed.

  • Prelude Capital Management's largest Q3 2018 buy was SodaStream International Ltd: 71,388 shares worth $10.2M.
  • Prelude Capital Management added most to CA, Inc. in Q3 2018, an estimated $32.4M increase.
  • Prelude Capital Management's biggest Q3 2018 reduction was NXP Semiconductors, cutting an estimated $20.6M.
  • Prelude Capital Management fully exited XL Group Ltd. in Q3 2018, selling an estimated $38M.
  • Prelude Capital Management's ten largest holdings make up 22% of its $1.72B portfolio in Q3 2018.
  • Prelude Capital Management opened 651 new positions and closed 573 in Q3 2018.
  • Prelude Capital Management's portfolio value rose 8.9% quarter-over-quarter to $1.72B.

Based on Prelude Capital Management's 13F filing for Q3 2018, filed 14 Nov 2018.